These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2176946

  • 61. [Ciliary body changes associate with aldose reductase in galactosemic rats (2)].
    Ikebe H, Terubayashi H, Okamoto S, Matsumoto Y, Tsutsumi M, Ibaraki N, Akagi Y.
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):860-4. PubMed ID: 1502985
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Lens aldose reductase.
    Jedziniak JA, Kinoshita JH.
    Exp Eye Res; 1969 Apr; 8(2):232. PubMed ID: 5786887
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Benzisothiazole-1,1-dioxide alkanoic acid derivatives as inhibitors of rat lens aldose reductase.
    Primofiore G, Da Settimo F, La Motta C, Simorini F, Minutolo A, Boldrini E.
    Farmaco; 1997 Oct; 52(10):583-8. PubMed ID: 9507669
    [Abstract] [Full Text] [Related]

  • 66. Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors.
    Kador PF, Kinoshita JH, Brittain DR, Mirrlees DJ, Sennitt CM, Stribling D.
    Biochem J; 1986 Nov 15; 240(1):233-7. PubMed ID: 3030278
    [Abstract] [Full Text] [Related]

  • 67. N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2.
    Malamas MS, Hohman TC.
    J Med Chem; 1994 Jun 24; 37(13):2059-70. PubMed ID: 8027987
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y, Ikebe H, Terubayashi H, Takahashi Y, Tsuji T.
    Nippon Ganka Gakkai Zasshi; 1989 Apr 24; 93(4):494-500. PubMed ID: 2508449
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Properties of an aldose reductase from pig lens. Comparative studies of an aldehyde reductase from pig lens.
    Branlant G.
    Eur J Biochem; 1982 Dec 24; 129(1):99-104. PubMed ID: 6819141
    [Abstract] [Full Text] [Related]

  • 77. The effect of an aldose reductase inhibitor on lens phosphorylcholine under hyperglycemic conditions: biochemical and NMR studies.
    Lou MF, Garadi R, Thomas DM, Mahendroo PP, York BM, Jernigan HM.
    Exp Eye Res; 1989 Jan 24; 48(1):11-24. PubMed ID: 2493385
    [Abstract] [Full Text] [Related]

  • 78. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats.
    Ghahary A, Luo JM, Gong YW, Chakrabarti S, Sima AA, Murphy LJ.
    Diabetes; 1989 Aug 24; 38(8):1067-71. PubMed ID: 2526763
    [Abstract] [Full Text] [Related]

  • 79. Rat lens aldose reductase: rapid purification and comparison with human placental aldose reductase.
    Herrmann RK, Kador PF, Kinoshita JH.
    Exp Eye Res; 1983 Nov 24; 37(5):467-74. PubMed ID: 6423398
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.